Education
About Us
Working with TipRanks
Follow Us
Med Biogene (TSE:MBI.H)
:MBI.H
MBI.H Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.03
Previous CloseN/A
VolumeN/A
Average Volume (3M)369.00
Market Cap
C$258.87K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Aug 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding17,257,837
10 Day Avg. Volume1,108
30 Day Avg. Volume369
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MBI.H FAQ
What was Med Biogene’s price range in the past 12 months?
Med Biogene lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.
What is Med Biogene’s market cap?
Med Biogene’s market cap is C$258.87K.
When is Med Biogene’s upcoming earnings report date?
Med Biogene’s upcoming earnings report date is Aug 22, 2025 which is in 69 days.
How were Med Biogene’s earnings last quarter?
Med Biogene released its earnings results on May 30, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Med Biogene overvalued?
According to Wall Street analysts Med Biogene’s price is currently Overvalued.
Does Med Biogene pay dividends?
Med Biogene does not currently pay dividends.
What is Med Biogene’s EPS estimate?
Med Biogene’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Med Biogene have?
Med Biogene has 17,257,837 shares outstanding.
What happened to Med Biogene’s price movement after its last earnings report?
Med Biogene reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Med Biogene?
Currently, no hedge funds are holding shares in TSE:MBI.H
Company Description
Med Biogene
Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with early-stage non-small-cell lung cancer.
Technical Analysis
Advanced Proteome Therapeutics
―
Aequus Pharmaceuticals
―
Imagin Medical
―
WPD Pharmaceuticals
―
NAVCO Pharmaceuticals Inc
―